Key molecular targets, especially in adenocarcinomas, include KRAS, ERBB2, and ARID1A. According to the recently published 5th edition of the World Health Organization classification, cervical cancer is classified as HPV-associated and HPV-independent for each histological type [35]. This evidence concerns the gene KRAS and adenocarcinoma.